According to the research report titled ‘Cell Harvesting Systems Market Share, Size, Trends, Industry Analysis Report By Techniques; By Application; By End User; By Regions, Segment Forecast, 2020 – 2026’, available with Market Study Report, global cell harvesting systems market is predicted to reach a valuation of USD 11.7 billion by the year 2026.
 

Increased pervasiveness of infectious and chronic diseases, rapid expansion of biotechnology companies and surging investments in cell research and regenerative activities are key factors propelling the growth of global cell harvesting systems market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2963757/
 

It is to be noted that stem cells are used to treat several chronic conditions. In this context, additional factors such as rising adoption of cell harvesting systems in stem cell banking and increasing number of transplant procedures are driving the market growth.
 

In fact, stem cell research has allowed scientists to understand the functions of the body as well as the relevant impact of a disease. It also helps in developing new treatments for rare and different diseases.
 

Rapid urbanization, rising adoption of sedentary lifestyle, increasing consumption of tobacco goods and high obesity rates have boosted the mortality rates across the globe. In addition, escalating expenditure towards treatment of life-and age-related chronic conditions is further stimulating global cell harvesting systems industry outlook.
 

High number of bone marrow transplant surgeries owing to rising prevalence of anemia and blood cancer coupled with mounting spending towards logistical operations are further aiding worldwide cell harvesting systems market expansion. However, some factors such as high treatment costs, lack of recovery measures and inadequate resources for identifying stem cells among adults may hinder the industry remuneration in the forthcoming years.
 

Considering the geographical landscape, North America is estimated to capture a substantial share in global cell harvesting industry by the end of the forecast period, with U.S. being a key contributor. Supportive federal initiatives, escalating R&D investments, and rising adoption of bone marrow stem cells transplant procedure for treating patients with chronic ailments are facilitating the business scenario in North America.
 

Arthrex Inc., Teleflex Inc., Argos Technologies Inc., Avita Medical, HynoDent AG, Terumo BCT Inc., Bertin Technologies, TOMTEC Imaging Systems GmbH, PerkinElmer Inc. are the prominent companies operating in global cell harvesting systems market.